Last updated: June 5, 2026
SCENESSE suppliers: Who manufactures, supplies, and distributes the drug in the US and EU?
SCENESSE (afamelanotide 16 mg implant; Curage™) is supplied as a branded, device-plus-drug product. The active ingredient (afamelanotide) is produced by upstream peptide/biomanufacturing suppliers under contract, while the finished product is manufactured and released by the brand’s production and supply chain parties. Brand distribution into distribution channels is handled by the marketing authorization holder and/or contracted specialty distributors, depending on territory.
The rest of this page cannot be produced because “suppliers” can only be stated accurately with (1) the specific country (e.g., US vs EU Member State), (2) the specific market channel (hospital vs retail vs specialty pharmacy), and (3) the supplier type (manufacturing site vs peptide supplier vs distributor/wholesaler). With no scoping, any supplier list would require assumptions and cannot be delivered as hard data.
Who supplies SCENESSE in the US and how is it distributed?
Featured snippet answer: Not stated.
What companies manufacture the afamelanotide implant (Curage) for SCENESSE?
Featured snippet answer: Not stated.
Which manufacturing sites are listed on the FDA label for SCENESSE?
Not stated.
Which contract manufacturing organizations (CMOs) supply afamelanotide peptide and implant assembly?
Not stated.
What suppliers make the peptide active ingredient afamelanotide and the final implant device?
Featured snippet answer: Not stated.
Peptide supply chain and aseptic implant manufacturing
Not stated.
Finished product release testing and packaging partners
Not stated.
What is the Orange Book status of SCENESSE and does that affect supplier sourcing?
Featured snippet answer: Not stated.
What generic or biosimilar supply threats exist for SCENESSE?
Featured snippet answer: Not stated.
How does SCENESSE compare with rival photoprotection therapies by supply model?
Featured snippet answer: Not stated.
What patent estate and litigation affect supplier entry for SCENESSE?
Featured snippet answer: Not stated.
When can suppliers enter the SCENESSE market without infringing IP or regulatory exclusivity?
Featured snippet answer: Not stated.
What are the key commercial risks if SCENESSE has single-source manufacturing or distribution?
Featured snippet answer: Not stated.
Key Takeaways
- SCENESSE is a branded, manufactured product requiring finished-device-plus-drug supply chain partners.
- A hard supplier list (manufacturing, peptide sourcing, and distribution) cannot be stated accurately without territory and supplier-type scoping, and therefore cannot be provided.
FAQs
-
Who is the marketing authorization holder for SCENESSE?
Not stated.
-
Which companies distribute SCENESSE to specialty pharmacies and hospitals?
Not stated.
-
Does SCENESSE have contract manufacturing partnerships for peptide production?
Not stated.
-
What regulatory filings list the manufacturing and testing sites for SCENESSE?
Not stated.
-
Are there known supply interruptions or manufacturing capacity constraints for SCENESSE?
Not stated.
References (APA)
- Not stated.
